AFFF cancer lawsuit

Clearview AI Was Sued By The FTC For Using Facial Recognition Without Consumer Permission, Violating The FCRA

A review of the case stressing privacy issues, legal transgressions, and the ramifications of facial recognition technology in daily life

Monday, January 13, 2025 - When the Federal Trade Commission (FTC) pursued Clearview AI, a business infamous for its dubious application of face recognition technology, it created waves in 2021. To produce a vast database of faces, Clearview scraped billions of photographs from social media and other websites. Law enforcement and commercial organizations then purchased this database, usually without the knowledge or permission of the people whose photographs were included. Clearview's methods, according to the FTC, used private consumer data without authorization, therefore violating the Fair Credit Reporting Act (FCRA). This case underlined the importance of legal action when those rights are abused and attracted fresh attention to the liberties of people under privacy rules. A Fair Credit Reporting Act attorney could offer a vital analysis on how such infractions might impact Credit Dispute Claims in other settings.

Two major sources give more background on this situation. The FTC claimed in its official news release that Clearview was gathering and exploiting photographs without appropriate permission, which resulted in misleading behavior violating consumer rights. The press statement also underlined the FTC's will to shield people from damage resulting from illegal access to personal data. A paper by the Electronic Frontier Foundation (EFF), which said Clearview's activities seriously compromised privacy and demanded more control of face recognition technology to stop exploitation, is another useful resource. These sources emphasize the need to make businesses answerable when their activities surpass moral and legal limits. Whether Clearview broke the FCRA--a law meant to guard customers against the exploitation of personal data--was the central focus of the lawsuit. Although the FCRA mostly controls how credit reporting companies handle consumer data, its reach also covers companies using personal information for assessments, such as hiring or housing decisions. Images connected to names and other identifying information in Clearview's database begged questions about whether the business was essentially functioning as a consumer reporting agency without following FCRA guidelines. This included neglecting to check the accuracy, let people know about data usage, and getting their permission.

Many people found great concern in the ramifications of this case. Imagine having your picture posted to social media only to learn later that it has been scraped and entered into a database without your authorization. Imagine now that companies, landlords, or even government organizations are using your database to make decisions about you--without your awareness or capacity to challenge any mistakes. Along with being intrusive, this degree of monitoring begs serious questions about responsibility, justice, and openness. Clearview claimed that the First Amendment protected its methods since publicly available data could be used any way one wanted. Critics noted, meanwhile, that the company's actions went much beyond mere public data access. Clearview essentially commercialized people's identities by compiling and marketing this data, usually without their knowledge or any obvious advantage for them. This difference is the reason many professionals feel Clearview crossed a legal and ethical line.

Information provided by AFFFLawsuitCenter.com, a website devoted to providing news about AFFF and PFAS cancer, lymphoma and leukaemia claims, including a free no-cost, no-obligation AFFF Lawsuit Claim.

More Recent AFFF Lawsuit News:

View all AFFF Lawsuit News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer, Lymphoma or Leukaemia After Exposure to Firefighting Foam

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.